Coagulation Analyzers Market Accounted For A USD 7.9 Billion By 2024Posted by Neha Bora on January 22nd, 2020 San Francisco, 22 January 2020: The Report Coagulation Analyzers Market Analysis By Product, By Technology (Mechanical, Electrochemical) By Test Types (APTT, D-Dimer, Fibrinogen, PT) By End Use (Hospitals, Research Institutes) & Segment Forecasts, 2018 – 2024 The global Coagulation Analyzers s/reagents market is expected to reach USD 7.9 billion by 2024, according to a new report by Grand View Research, Inc. Rising technological advancements in Coagulation Analyzers s are expected to be the most impact rendering driver for lucrative growth of the market. Automation is the key development that has occurred in recent years. The most relevant advancement includes combination of different assay procedures in single equipment and various commercially available hemostasis analyzers, which are capable of performing tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), D-Dimer, and Fibrinogen as well as these machines can perform chromogenic and immunologic assays. Moreover, these systems may have the capacity of holding more samples, providing faster results, and increasing the efficiency of laboratory workflow. The advancements in hemostasis analyzers are as follows:
Access Research Report of Coagulation Analyzers Market @ www.grandviewresearch.com/industry-analysis/coagulation-analyzers-market Further key findings from the study suggest:
Grand View Research has segmented the global Coagulation Analyzers s & Reagents market on the basis of product, technology, test type, end-use and region. Product Outlook (Revenue, USD Million, 2013 - 2024)
Technology Outlook (Revenue, USD Million, 2013 - 2024)
Test Type Outlook (Revenue, USD Million, 2013 - 2024)
End-Use Outlook (Revenue, USD Million, 2013 - 2024)
Regional Outlook (Revenue, USD Million, 2013 - 2024)
Like it? Share it!More by this author |